Abiopharma

🔍 SAMINI KEYVAN (Director)

Company: MOBIX LABS, INC (MOBX)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 12,500 shares of Class A Common Stock (Direct)
  Date: 2026-08-21 | Code: C | equity_swap_involved: 0 | shares_owned_after: 29,614.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-21 | Code: H | shares_owned_after: 155,053.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By KSLI Trust | shares_owned_after: 7,353.00 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By SSLI Trust | shares_owned_after: 7,352.00 | Footnotes: F1
• Sold 12,500 shares of Class B Common Stock (Derivative)
  Date: 2026-08-21 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F1
• Holds 32,353 shares of Option (Right to Buy) at $1.7 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2030-08-10 | shares_owned_after: 32,352.00 | Footnotes: F2

Footnotes:

• F1: The Reporting Person is a trustee of this trust. The Reporting Person disclaims beneficial ownership of the securities held by this trust except to the extent of his respective pecuniary interest therein.
• F2: These options are fully vested and exercisable.
• F3: Represents the conversion, on a one-for-one basis, of all 12,500 shares of Class B Common Stock held by the KSSF Trust into 12,500 shares of Class A Common Stock, pursuant to the terms of the Company's Certificate of Incorporation. No consideration was paid in connection with the conversion.